Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

213
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

149
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Nitric oxide mediated effects of nebivolol in cardiorenal syndrome

Pages

  1314-1324

Abstract

 Objective(s): Despite several proposed mechanisms for the pathophysiology of Cardiorenal syndrome (CRS), the exact mechanism remains unclear. Nitrosative stress has been argued as a key mechanism recently. Nebivolol is a beta-blocker with Nitric oxide (NO)-releasing effect. In the present study, NOmediated effects of two different treatment regimes of Nebivolol in CRS were studied. Materials and Methods: Rats were divided into: sham-operated (sham-control), Myocardial infarction (MI)-induced, (MI-control) early Nebivolol-treated (MI-neb1) and late Nebivolol-treated (Mı-neb2) groups. The effects of Nebivolol were assessed both in the early and late period of MI by histologic, hemodynamic and biologic studies. Results: Developed MI model was in line with the heart failure with preserved ejection fraction. Focal and total tubular damage findings were observed in MI-control group both in early and late period of MI. In parallel, subclinical functional damage was transformed into chronic renal dysfunction in this group. Increased inducible Nitric oxide synthase (iNOS) and endothelial NOS (eNOS) together with decreased neuronal NOS (nNOS) levels were in parallel with the increased inflammation and nitrosative stress biomarkers. Nebivolol effectively prevented both subclinical and clinical nephropathy. There was no statistical difference between the Nebivolol treatment regimes. Conclusion: The beneficial effects of Nebivolol were closely related to the reduction of Nitrosative damages as well as hemodynamic alterations. The NO-mediated effects were: prevention of Nitrosative damage by decreasing iNOS, preservation of nNOS in order to maintain glomerular filtration rate (GFR), and restoration of eNOS in the late period of MI. On contrary to our previous work, early Nebivolol administration had a similar effect with delayed administration of Nebivolol on CRS.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Mercanoglu, Guldem, & Semen, Onder. (2019). Nitric oxide mediated effects of nebivolol in cardiorenal syndrome. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(11), 1314-1324. SID. https://sid.ir/paper/730129/en

    Vancouver: Copy

    Mercanoglu Guldem, Semen Onder. Nitric oxide mediated effects of nebivolol in cardiorenal syndrome. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(11):1314-1324. Available from: https://sid.ir/paper/730129/en

    IEEE: Copy

    Guldem Mercanoglu, and Onder Semen, “Nitric oxide mediated effects of nebivolol in cardiorenal syndrome,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 11, pp. 1314–1324, 2019, [Online]. Available: https://sid.ir/paper/730129/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top